Dulaglutide for type 2 diabetes (Trulicity)
Comprehensive guide to Trulicity (dulaglutide), a once-weekly GLP-1 agonist for managing type 2 diabetes in adults and children over 10.
Dulaglutide, sold under the brand name Trulicity, is a once-weekly injectable medication classified as a GLP-1 receptor agonist used to treat type 2 diabetes in adults and children aged 10 years and older. It helps control blood sugar levels alongside diet and exercise, and reduces cardiovascular risks in patients with heart disease.
About dulaglutide
Dulaglutide mimics the action of glucagon-like peptide-1 (GLP-1), a gut hormone that enhances insulin secretion from the pancreas in response to meals, suppresses glucagon release (which raises blood sugar), and slows gastric emptying to prevent post-meal spikes. This multi-action mechanism improves glycemic control without a high risk of hypoglycemia when used alone.
Approved by the FDA in 2014 and authorized in the EU, Trulicity is indicated as monotherapy when metformin is unsuitable or in combination with other antidiabetic drugs. Clinical trials demonstrate reductions in HbA1c levels, with benefits across age, sex, race, and diabetes duration subgroups.
In addition to blood sugar management, it lowers the risk of major adverse cardiovascular events (MACE) like heart attack, stroke, or cardiovascular death in adults with type 2 diabetes and established heart disease.
Before taking dulaglutide
Allergies
Do not use dulaglutide if you have a history of serious hypersensitivity reactions to dulaglutide or its components, such as anaphylaxis or angioedema.
Pregnancy and breastfeeding
Avoid dulaglutide during pregnancy due to potential fetal harm observed in animal studies; use effective contraception. It is not recommended while breastfeeding, as safety data are limited.
Other medical conditions
- Thyroid cancer risk: Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), due to rodent thyroid C-cell tumor findings.
- Pancreatitis: Use with caution if history of acute pancreatitis; discontinue if symptoms like severe abdominal pain occur.
- Gastroparesis or bowel issues: Not recommended, as it slows gastric emptying.
- Kidney or liver problems: No dose adjustment needed, but monitor closely.
- Heart failure: Monitor for fluid retention when combined with insulin or sulfonylureas.
How and when to take dulaglutide
Dosage
Start with 0.75 mg once weekly, increasing to 1.5 mg after at least 4 weeks if better control is needed. Maximum dose is 4.5 mg weekly in some regimens. Administer regardless of meals.
| Patient Group | Starting Dose | Maintenance/Increment |
|---|---|---|
| Adults | 0.75 mg weekly | Increase to 1.5 mg, up to 4.5 mg if needed |
| Children ≥10 years | 0.75 mg weekly | Adjust based on response |
Administration
Trulicity is a single-use prefilled pen injected subcutaneously into the abdomen, thigh, or upper arm. Rotate sites weekly. Store in refrigerator (2–8°C); can be kept at room temperature up to 21 days. Do not freeze or use if discolored.
- Check pen, wash hands.
- Choose injection site, clean with alcohol.
- Unlock pen, press button for 5–10 seconds until dose counter shows zero.
- Dispose safely.
Miss a dose if within 3 days of next; otherwise, skip and resume schedule.
Side effects of dulaglutide
Common side effects (affecting >1 in 10) include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite, often mild and decreasing after 2 weeks.
Serious side effects
- Acute pancreatitis: Severe abdominal pain radiating to back, with vomiting (rare, ~0.1–1%). Stop and seek medical help.
- Hypoglycemia: Low when combined with insulin/sulfonylureas (~8% mild, 0.2% severe); symptoms include shakiness, sweating.
- Thyroid tumors: Neck lump, hoarseness, trouble swallowing (monitor).
- Kidney injury: From dehydration due to GI effects.
- Allergic reactions: Rash, swelling, breathing difficulty.
- Gallbladder disease: Cholecystitis, increased risk.
Weight loss (2–3 kg average) is common and beneficial.
How to cope with side effects
- Nausea/vomiting: Eat smaller meals, avoid fatty foods; usually resolves.
- Diarrhea: Stay hydrated, use over-the-counter remedies if needed.
- Hypoglycemia: Consume fast-acting carbs (glucose tabs), check blood sugar.
- Injection site reactions: Rotate sites, use warm compress.
Report persistent or severe effects to your doctor; dose adjustment or discontinuation may be required.
Drug interactions with dulaglutide
Dulaglutide slows gastric emptying, affecting oral medication absorption (e.g., acetaminophen, antibiotics). Separate by 1 hour if needed. Increased hypoglycemia risk with insulin/sulfonylureas—reduce doses. No major CYP interactions.
| Drug Class | Interaction | Management |
|---|---|---|
| Insulin/Sulfonylureas | Increased hypoglycemia | Reduce dose, monitor glucose |
| Oral meds (e.g., contraceptives) | Delayed absorption | Monitor efficacy |
| Warfarin | Potential INR changes | Monitor INR |
Common questions about dulaglutide
How long does dulaglutide take to work?
Improvements in blood sugar seen within weeks; full HbA1c reduction in 3–6 months.
Does dulaglutide cause weight gain?
No, it promotes modest weight loss (1–4 kg), aiding obesity-related diabetes.
Can I drink alcohol with dulaglutide?
Moderate use okay, but monitor for hypoglycemia and GI upset.
Is dulaglutide safe for kidneys?
Generally yes, but hydrate to prevent dehydration-related issues.
Can children use Trulicity?
Yes, approved for ages 10+ as adjunct to diet/exercise.
Important information
Trulicity is prescription-only. Regular monitoring of blood sugar, kidney function, and thyroid is essential. Cardiovascular benefits are proven in high-risk adults. No mortality benefit shown. Combine with lifestyle changes for best results.
References
- Trulicity | European Medicines Agency (EMA) — EMA. 2023. https://www.ema.europa.eu/en/medicines/human/EPAR/trulicity
- Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus — American Academy of Family Physicians (AAFP). 2017-10-15. https://www.aafp.org/pubs/afp/issues/2017/1015/p540.html
- Trulicity for Type 2 Diabetes: How It Works, Benefits, and Side Effects — Boca Pharmacy Group. 2024. https://bocapharmacygroup.com/trulicity-for-type-2-diabetes-how-it-works-benefits-and-side-effects/
- Trulicity (Dulaglutide): A New GLP-1 Receptor Agonist Once-Weekly — PMC (NCBI). 2015-11-01. https://pmc.ncbi.nlm.nih.gov/articles/PMC4665063/
- Trulicity (dulaglutide) – Uses, Side Effects, and More — WebMD. 2025. https://www.webmd.com/drugs/2/drug-167025/trulicity-subcutaneous/details
- Dulaglutide (subcutaneous route) — Mayo Clinic. 2025. https://www.mayoclinic.org/drugs-supplements/dulaglutide-subcutaneous-route/description/drg-20122526
Similar Articles
Read full bio of Sneha Tete
